Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aaa, accuracy, acquiree, adolescent, Alameda, Amendola, andBeebout, andDonald, anthracycline, anticoagulant, antineoplastic, antisense, Assoc, attractive, auction, authoritative, Avista, Baxter, Beebout, belonging, benchmark, BIOTECanada, bought, boycotted, broader, Bureau, capecitabine, Carolina, Coincident, concerted, constitute, contraindicated, convertase, counted, counterparty, culture, dairy, deconsolidated, deconsolidation, deferral, defray, delegated, derecognition, derecognized, dermatology, disbursed, distinguish, diverse, Docket, doubtful, dutch, endeavor, equivalization, Ferrara, footprint, forinter, forum, Frank, FRS, Fung, fur, gastric, GenRx, GmbH, hospital, HZI, Iceland, idiopathic, illiquid, impending, InBeth, India, inefficient, inhibiting, InKin, intervene, Italian, IXEMPRA, juvenile, kexin, KIPT, Labor, Lai, lapsed, LEK, Lion, literature, loading, LPR, mathematical, maximize, Mayaguez, mCRC, MDD, mediation, MI, microtubule, mid, modest, multiplying, nearby, nimble, noncontrolling, NSD, Oceanic, odor, Ontario, outsourcing, overtime, owner, parent, paydown, Pharmastar, predecessor, predetermined, properly, proprietary, proprotein, Protocol, proven, PTI, RA, radiology, ratified, recaptured, recordkeeping, recurrent, Robinson, serum, shortage, slight, Slovenian, statistically, subtilisin, survival, taxane, theAmendola, theKin, thereto, thrombotic, title, transmitted, unhedged, unreasonable, unweighted, wage, Zealand
Removed:
abnormal, ACO, administrator, admitting, amend, antibiotic, appraisal, Army, art, assignment, attention, automatically, averaged, bacterial, Bay, BG, biologically, black, blood, box, build, cancelled, cap, capsule, captionIn, cardiac, CARDIOLITE, cefprozil, CEFZIL, cephalosporin, Chapter, chemically, Chemistry, cited, Clairol, clarifying, CMS, cogeneration, commencing, compensatory, conditionally, contest, contingency, converting, cooperate, cooperation, cooperative, coordinate, correctly, creating, dealing, death, deduction, DEFINITY, DELESTROGEN, demonstrable, denied, denying, detailing, didanosine, discontinue, dismissal, divested, divided, dividing, dovetail, duty, ear, eighty, eleven, ENFAGROW, enhanced, enzyme, equitable, ESTRACE, estradiol, evaluate, expert, Exploratory, factual, fall, FIFO, fifteen, focusing, foregoing, forfeited, fosinopril, fraudulently, GLUCOPHAGE, GLUCOVANCE, growing, guaranty, headquartered, hepatic, hormone, HRT, ideally, idle, inflating, initiated, injection, Inland, insert, install, institution, intermediate, invoice, joined, justifiable, knew, Kyorin, led, licensure, liquidated, Lonza, mammalian, manager, mandated, migrated, misconduct, misleading, Missouri, mistakenly, MIT, monitoring, monoamine, moved, Mylan, Newark, ninety, node, nonexclusive, nonmonetary, Northern, NRD, nuclear, opportunity, opt, ordinary, OVCON, overpayment, oxidase, package, paper, participated, patch, Pennsylvania, pilot, platinol, posed, proceeding, punitive, pursuing, qualified, rapidly, recalculated, recalculation, receiving, relying, removed, repatriating, requirement, residual, resolved, respiratory, respond, retention, revert, revision, rigid, selegiline, sicor, sixty, skilled, sooner, Southeast, speed, Spill, stavudine, Steering, stopped, substance, synthesized, throat, tract, training, transdermal, transplantation, transportation, treated, turbine, turn, valid, violate, warn, warning, watershed, wholly, worked, wrong, wrongdoing, XR, Yale, Yamasa, ZERIT, Zimmer
Filing tables
Filing exhibits
- 10-K Annual report
- 10 Form of Agreement
- 12 Statement Re Computation of Ratios
- 21 Subsidiaries of the Registrant
- 23 Consent of Deloitte & Touche LLP
- 23 Consent of Pricewaterhousecoopers LLP
- 31 Section 302 CEO Certification Letter
- 31 Section 302 CFO Certification Letter
- 32 Section 906 CEO Certification Letter
- 32 Section 906 CFO Certification Letter
Related press release
BMY similar filings
Filing view
External links
EXHIBIT 12.
Computation of Earnings to Fixed Charges
Five-Year Ratio of Earnings to Fixed Charges:
Dollars in Millions | 2007 | 2006 | 2005 | 2004 | 2003 | |||||||||||||||
Earnings | ||||||||||||||||||||
Earnings from continuing operations before minority interest and income taxes | $ | 3,534 | $ | 2,400 | $ | 4,304 | $ | 4,210 | $ | 4,529 | ||||||||||
Less: | ||||||||||||||||||||
Equity in net income of affiliates | 524 | 474 | 334 | 273 | 151 | |||||||||||||||
Income adjusted for equity income | 3,010 | 1,926 | 3,970 | 3,937 | 4,378 | |||||||||||||||
Add: | ||||||||||||||||||||
Fixed charges | 512 | 566 | 408 | 369 | 361 | |||||||||||||||
Distributed income of equity investments | 409 | 439 | 383 | 278 | 155 | |||||||||||||||
Pre-tax losses of equity investees | 12 | 10 | 9 | 3 | 40 | |||||||||||||||
Less: | ||||||||||||||||||||
Capitalized interest | (35 | ) | (18 | ) | (9 | ) | (10 | ) | (35 | ) | ||||||||||
Total Earnings | $ | 3,908 | $ | 2,923 | $ | 4,761 | $ | 4,577 | $ | 4,899 | ||||||||||
Fixed Charges | ||||||||||||||||||||
Interest and debt expense | $ | 422 | $ | 498 | $ | 349 | $ | 310 | $ | 277 | ||||||||||
Capitalized interest | 35 | 18 | 9 | 10 | 35 | |||||||||||||||
One-third of rental expense(1) | 55 | 50 | 50 | 49 | 49 | |||||||||||||||
Total Fixed Charges | $ | 512 | $ | 566 | $ | 408 | $ | 369 | $ | 361 | ||||||||||
Ratio of Earnings to Fixed Charges | 7.63 | 5.16 | 11.67 | 12.40 | 13.57 |
(1) | Rents included in the computation consist of one-third of rental expense which we believe to be a conservative estimate of an interest factor in our leases, which are not material. |
E-12-1